(CLBT) Cellebrite DI - Ratings and Ratios

Cellebrite DI Ltd. (NASDAQ:CLBT) is a global leader in digital intelligence solutions, providing advanced tools for legally sanctioned investigations across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The companys DI suite of solutions empowers users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data throughout the investigative lifecycle. These solutions are critical in cases involving child exploitation, homicide, anti-terror operations, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency investigations, and intellectual property theft.

The companys flagship product, Inseyets, is a digital forensics software designed to collect and review digital evidence from a wide range of digital sources. It offers advanced capabilities such as data extraction, decoding, customizable workflows, and automation. Additionally, Cellebrite provides Cellebrite Pathfinder, which automates data analysis and visualization to reduce manual review time; Smart Search, an open-source intelligence tool for automating the collection and review of publicly available online data; and Guardian, a comprehensive case and evidence management solution.

Cellebrite also offers a suite of digital forensic software tailored for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now. These solutions are complemented by professional services such as training and certification programs, as well as advanced services. The company primarily serves federal, state, and local agencies worldwide. Headquartered in Petah Tikva, Israel, Cellebrite is a key player in the digital forensics and investigative technology space, enabling law enforcement and other organizations to tackle complex investigative challenges effectively.

Ticker Symbol: CLBT
Exchange: NASDAQ
Type: common stock
Country Origin: Israel
GICS Sub Industry: Application Software

Average Volume 20d: 920718
Last Price: 19.64
SMA 20: 18.92
SMA 50: 18.87
SMA 200: 18.56
ATR: 0.90

Market Cap: 4525.98M USD
P/E: None
P/E Forward: 37.17
P/B: 13.47
P/S: 11.28
RoE: None

3 Month Forecast:
Based on technical and fundamental data, Cellebrite DI Ltd. (NASDAQ:CLBT) is expected to experience moderate volatility with potential upside driven by its high forward P/E ratio of 37.17, indicating market expectations for growth. The stocks price movement is likely to remain above its SMA 200 of 18.56, supported by its current price of 19.64, which is slightly above its SMA 20 of 18.92. However, the high P/S ratio of 11.28 and P/B ratio of 13.47 may lead to valuation concerns. The ATR of 0.90 suggests moderate price fluctuations over the next quarter.